U.S. Markets closed

IBD 50 Growth Stocks To Watch: After Climbing 403% From A 2009 Breakout, Can This Biotech Surge Again?

DAVID SAITO-CHUNG
IBD 50 Growth Stocks To Watch: After Climbing 403% From A 2009 Breakout, Can This Biotech Surge Again?

Earnings are rising again and revenue growth is accelerating at Alexion Pharmaceuticals, one of the current top growth stocks to watch in the IBD 50.